Aspira Women's Health Inc.

AWHL · OTC · SIC 2835: In Vitro & In Vivo Diagnostic Substances
381
SEC Filings

Business Summary

Aspira Women's Health Inc. is a commercial-stage diagnostics company focused on gynecological disease detection in women. The company develops and markets diagnostic tests including Ova1, Overa, Ova1Plus, OvaWatch, ENDOinform, and OVAinform for ovarian cancer risk assessment, endometriosis, and benign pelvic mass monitoring. Operating through its laboratory subsidiary Aspira Labs, the company also offers the Aspira Synergy platform and Aspira Genetix genetic testing services.

Next Earnings

Q2 FY2026 — expected 2026-09-14

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionAWHLdiscussed_in_filing Artificial Intelligence
topic_mentionAWHLdiscussed_in_filing Cybersecurity
topic_mentionAWHLdiscussed_in_filing Trusted Computing
topic_mentionAWHLdiscussed_in_filing Blockchain & Crypto
topic_mentionAWHLdiscussed_in_filing Regulation
topic_mentionAWHLdiscussed_in_filing Healthcare & Bio
topic_mentionAWHLdiscussed_in_filing Platform & Ecosystem
topic_mentionAWHLdiscussed_in_filing Sovereign & Government
topic_mentionAWHLdiscussed_in_filing Artificial Intelligence
topic_mentionAWHLdiscussed_in_filing Cybersecurity
topic_mentionAWHLdiscussed_in_filing Trusted Computing
topic_mentionAWHLdiscussed_in_filing Blockchain & Crypto
topic_mentionAWHLdiscussed_in_filing Regulation
topic_mentionAWHLdiscussed_in_filing Healthcare & Bio
topic_mentionAWHLdiscussed_in_filing Platform & Ecosystem
topic_mentionAWHLdiscussed_in_filing Sovereign & Government
topic_mentionAWHLdiscussed_in_filing Artificial Intelligence
topic_mentionAWHLdiscussed_in_filing Cybersecurity
topic_mentionAWHLdiscussed_in_filing Trusted Computing
topic_mentionAWHLdiscussed_in_filing Blockchain & Crypto

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-04-012025-12-310000926617-26-000020EDGAR64K words
2025-03-272024-12-310001641172-25-000983EDGAR—
2024-04-012023-12-310000926617-24-000015EDGAR—
2023-03-302022-12-310000926617-23-000026EDGAR—
2022-03-312021-12-310000926617-22-000014EDGAR—
2021-03-312020-12-310000926617-21-000033EDGAR—
2020-04-072019-12-310000926617-20-000015EDGAR—
2019-03-282018-12-310000926617-19-000007EDGAR—
2018-03-132017-12-310000926617-18-000012EDGAR—
2017-03-312016-12-310000926617-17-000023EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-142025-09-300000926617-25-000008EDGAR28K words
2025-08-132025-06-300001493152-25-011865EDGAR—
2025-05-192025-03-310001641172-25-011399EDGAR—
2024-11-192024-09-300001493152-24-046836EDGAR—
2024-08-132024-06-300000950170-24-096220EDGAR—
2024-05-152024-03-310000950170-24-060401EDGAR—
2023-11-132023-09-300000926617-23-000095EDGAR—
2023-08-142023-06-300000926617-23-000070EDGAR—
2023-05-152023-03-310000926617-23-000046EDGAR—
2022-11-102022-09-300000926617-22-000058EDGAR—
2022-08-102022-06-300000926617-22-000052EDGAR—
2022-05-112022-03-310000926617-22-000032EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-01-300000926617-26-000007EDGAR14K words
2025-12-310000926617-25-000014EDGAR—
2025-12-230001104659-25-124245EDGAR—
2025-12-220000926617-25-000010EDGAR—
2025-11-140000926617-25-000004EDGAR—
2025-10-150001493152-25-018146EDGAR—
2025-09-250001493152-25-014925EDGAR—
2025-09-180001493152-25-013987EDGAR—
2025-09-030001641172-25-026441EDGAR—
2025-08-130001493152-25-011867EDGAR—

381 total filings indexed. 349 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

ACHV — ACHIEVE LIFE SCIENCES, INC. TKNO — Alpha Teknova, Inc. BMRA — BIOMERICA INC BZYR — BURZYNSKI RESEARCH INSTITUTE INC CDIO — Cardio Diagnostics Holdings, Inc. CLDX — Celldex Therapeutics, Inc. IDXX — IDEXX LABORATORIES INC /DE ICCC — IMMUCELL CORP /DE/

Tags

ovarian-cancer-diagnostics endometriosis-diagnostics gynecological-disease-diagnostics women's-health clinical-laboratory-services laboratory-developed-tests-(ldts) fda-clearance/approval-standards-for-medical-devices

Company Identity

CIK0000926617
TickerAWHL
ExchangeOTC
SIC2835: In Vitro & In Vivo Diagnostic Substances
IncorporatedDE

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 07baebb49155e786491c4f4a40792025fa3fbb8f9e83c2ba7c6e3d066138deeb
parent: a79e220a90986070c9313e48708c68c8d7c1963890e1b6d444ddfaddef49e0e8
content hash: 87a57f2d68dc4865f0cf90b845d6974d21b8c1df82cdf0fd3807f8fd8180a59e
signed: 2026-04-13T04:43:49.955Z
sources: 22 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf